• Patient Portal
  • Telehealth portal 
  • Wellness portal 
  • Blog
  • Home
  • About
  • Referrals
  • Contact
  • Dream Project
  • Infectious Diseases

    Excellence in patient care, education, research, public health, and prevention relating to infectious diseases.

  • Wellness

    Regional Wellness Center- For a healthier you

  • Wound Care

    Advanced healing with basic and latest techniques

  • Clinical Research

    Giving patients access to Experimental Treatments before they are widely available

  • Infusion Center

    Delivery of extraordinary patient care in outpatient setting

  • Hyperbaric Oxygen Therapy

    Promoting healing using oxygen

  • Infection Control

    Prevent and control healthcare-associated infections

  • Regenerative Medicine

    Process of regenerating human cells, tissues or organs to restore or establish normal function

  • Telemedicine

    Your doctor anywhere - Leading the way in excellent patient care

Our Services

  • Infectious Diseases
  • Infection Control
  • Clinical Research
  • Wound Care
  • For Pharmaceutical Companies
  • Hyperbaric Oxygen Therapy
  • Interesting Links
  • Office Policy
  • Terms of Use and Disclaimers
  • Ambulatory Infusion Suite
  • For HealthCare Providers
  • Medical Services

    Medical Services

    Infectious Disease Consultations (Diagnosis and management of infections)

    Read More
  • Affiliations

    Affiliations

    RIDIC is closely affiliated with the following Hospitals..

    Read More
  • Patient Education

    Patient Education

    By health professionals and others provide impart information to patients.

    Read More
  • Community Involvement

    Community Involvement

    RIDIC Involved in community health fair and some other..

    Read More

Mission Statement

RID-IC provides infectious diseases services including: direct patient care, diagnosis and treatment of infectious diseases, infusion services, and wound care. To that end, a patient-centered office that provides cost effective care has been developed.

Read More

Patient Comments

I am recovering from a illness that could have been very serious. Thanks to my wonderful doctors, Vivian Hobayan, Ravi Kamepalli, and William Sanko, for their prompt diagnosis and treatment.

Read More

Practical Approach to Problem Wounds

Practical Approach to Problem Wounds

To view the full length Video

Please fill the form

*Once you submit you will get a email with a password for the video.

Company Research Articles and Presentations

  • Click Here Poster for Fecal Bacteriotherapy Treatment for Clostridium Difficile Infection- "Presented at ID WEEK 2013"
  • Click Here PRP with small Intestine Submucosa Layer(SIS) poster - "Presented at SAWC Spring 2013"
  • Click Here PRP poster for complex surgical wounds - "Presented at SAWC FALL 2011"

 

What is Microbiome?

 

Infectious Diseases Feed

  • Parents understand cold prevention; most still use unproven strategies
    Nearly all parents participating in a nationally representative poll follow evidence-based cold prevention strategies for their children, including...
  • Beta-lactam/daptomycin combo does not reduce mortality rates in patients with MSSA bacteremia
    The combination of a beta-lactam and daptomycin did not improve outcomes in patients with methicillin-susceptible Staphylococcus aureus, or MSSA,...
  • Tafenoquine prevents P. vivax relapse; further study needed
    Tafenoquine is effective for the radical cure of Plasmodium vivax malaria, and a single-dose regimen resulted in a significantly lower risk of P....
  • No differences in CDI-related complications between toxin-positive and NAAT-positive-only CDI
    Toxin-positive Clostridioides difficile infection, or CDI, tended to be more severe than CDI that was detected through nucleic acid amplification...
  • Trial testing FMT for recurrent diarrheal disease begins
    A research consortium across multiple institutions has begun enrolling patients in a clinical trial examining whether fecal microbiota...
  • Malaria vaccine candidate PAMVAC passes test in humans
    A recent phase 1 clinical trial of the malaria vaccine candidate PAMVAC, designed to protect against pregnancy-associated malaria, or PAM, found...
  • WHO announces 10 threats to global health in 2019
    WHO announced a list of 10 health issues that will require their attention in 2019. To address these issues, WHO is beginning a 5-year strategic...
  • HepVu releases interactive online maps for state-level HCV estimates
    HepVu — an interactive online resource designed to visualize data on the U.S. hepatitis C epidemic — announced the release of new interactive maps...
  • HAdV-7d outbreak underscores need to consider adenoviruses as cause of respiratory illness
    Researchers reporting on a deadly outbreak of human adenovirus type 7d, or HAdV-7d, said clinicians and public health authorities should consider...
  • Mortality 6 times higher in CP-CRE carriers subsequently infected with a different genotype
    Researchers found that patients colonized with carbapenem-producing carbapenem-resistant Enterobacteriaceae, or CP-CRE, who are subsequently...
  • Combination therapy 88% effective against HIV, leishmaniasis coinfection
    Extended treatment with a combination of AmBisome plus miltefosine is 88% effective in treating patients with HIV and visceral leishmaniasis...
  • Treatment de-intensification fails to reduce toxicity, maintain efficacy in HPV-positive oropharyngeal cancer
    Patients with advanced, HPV-positive oropharyngeal squamous cell carcinoma did not experience significant reductions in toxicity from treatment...
  • WHO raises concern about infectious disease risk in Syrian settlement
    WHO expressed “severe concern” today over the conditions in the Rukban settlement in Syria, located near the border of Jordan, where approximately...
  • Undiagnosed HBV, HCV, HIV prevalent in newly diagnosed cancer cases
    Researchers discovered a substantial proportion of patients with newly diagnosed cancer and concurrent hepatitis C or hepatitis B were unaware of...
  • Medicare Part B to D shift may decrease total spending, increase out-of-pocket costs
    Although a proposal by the HHS to shift certain prescription drugs from Medicare Part B to Part D may reduce total drug spending by 6.9% to 18.3%,...
  • Dermatologists prescribing more antibiotics following surgical visits
    Antibiotic prescribing by dermatologists has “substantially decreased” in recent years, mostly due to a drop in prescriptions for acne and rosacea,...
  • Rate of late-onset GBS in infants surpasses early-onset cases
    The rate of early-onset disease caused by group B Streptococcus, or GBS, has decreased among infants in the United States between 2006 and 2015,...
  • Imported cases of Lassa fever often missed for days
    From 1969 to 2016, 33 cases of Lassa fever were diagnosed in travelers from West Africa to nine other countries, according to a new report....
  • Food supply at ‘extremely low risk’ for increased contamination during shutdown
    With FDA food safety inspectors furloughed during the government shutdown, media reports indicated concern that food facilities would not be...
  • Shigella shows high resistance to azithromycin, ciprofloxacin
    More than half of tested Shigella isolates obtained from men who have sex with men, or MSM, in an Australian state demonstrated resistance to...

Quick Menu

  • Home
  • About Us
  • Medical Services
  • Affiliations
  • Patient Education
  • Community Involvement
  • Mission Statement
  • Patient Comments

Services

  • Infectious Diseases
  • Infection Control
  • Clinical Research
  • Wound Care
  • For Pharmaceutical Companies
  • Hyperbaric Oxygen Therapy
  • Interesting Links
  • Office Policy
  • Terms of Use and Disclaimers
  • Ambulatory Infusion Suite
  • For HealthCare Providers

Address

Regional Infectious Diseases and Infusion center, Inc.

830 West High street,
Suite 255, Lima,
OH 45801 USA

Telephone: 419-228-1535
Fax: 419-227-1410
Research Department Fax: 419-228-1532
Mobile: 1-877-537-4342

© 2019 NO BAD BUGS